Quantcast
Everest Expedition Provides First Evidence Of Effects Of

Everest Expedition Provides First Evidence Of Effects Of Altitude On Blood Pressure

Emma Mason, European Society of Cardiology Cardiovascular patients should be cautious when exposed to high altitudes for leisure or work An expedition to Mount Everest by Italian researchers has shown for the first time that blood pressure...

Latest Pulmonology Stories

2014-08-26 12:27:14

Sales of the LABA/LAMA Combination Drug Class are Expected to Grow Significantly Over the Next Six Months, According to Findings from Decision Resources Group BURLINGTON, Mass., Aug. 26, 2014 /PRNewswire/ -- Decision Resources Group finds that two-thirds of surveyed pulmonologists indicate that Boehringer Ingelheim's Spiriva is the agent most likely to be replaced by GlaxoSmithKline/Theravance's first-in-class LABA/LAMA combination Anoro Ellipta. To date, surveyed physicians reported that, of...

2014-08-19 12:29:01

New respiratory therapy device uses sound waves at different frequencies to promote Airway Clearance Therapy (ACT). TUSCON, Ariz., Aug. 19, 2014 /PRNewswire/ -- Westmed, Inc., a leader in the design, manufacture and marketing of medical devices used in respiratory therapy and anesthesia, announced today that the U.S. Food and Drug Administration (FDA) has granted it 510(k) clearance to market the company's Vibralung(®) Acoustical Percussor. The device is intended for use by...

2014-08-19 12:28:32

For U.S. Media Only RIDGEFIELD, Conn., Aug. 19, 2014 /PRNewswire/ -- Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) accepted for review the New Drug Application (NDA) for the fixed-dose combination (FDC) of tiotropium and olodaterol delivered via the Respimat(®) inhaler for the proposed indication of long-term, once-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including...

2014-08-14 16:27:26

Committee Voted Based on Clinical Data from Eight Efficacy Trials RIDGEFIELD, Conn., Aug. 14, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) voted [10 yes, 3 no] that existing data supports approval of Boehringer Ingelheim's investigational tiotropium bromide inhalation spray for long-term, once-daily maintenance treatment of bronchospasm associated...

2014-08-01 08:26:18

For U.S. Media Only RIDGEFIELD, Conn., Aug. 1, 2014 /PRNewswire/ -- Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) has approved Striverdi(®) Respimat(®) (olodaterol) Inhalation Spray 5 mcg as a long-term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. STRIVERDI RESPIMAT is not indicated to treat acute...

2014-07-28 13:25:26

University of Manchester Scientists from The University of Manchester have discovered why medication to treat asthma and pneumonia can become ineffective. The findings, published in Nature Medicine, show that drugs widely used to treat lung diseases work with the body clock. In the UK pneumonia, which is caused by an infection, affects around 1 in 1000 adults each year and is more serious for babies, young children, the elderly, smokers and those with an underlying health condition....

2014-07-24 08:31:52

ANDOVER, Mass., July 24, 2014 /PRNewswire/ -- ndd Medical Technologies, a leader in innovative mobile pulmonary function testing (PFT) employing precise ultrasound technology, announced that its EasyOne Pro(®) has been chosen as the instrument to measure Carbon Monoxide Diffusing Capacity (DLCO) for phase 2 of the COPDGene(®) Study, the most comprehensive study of Chronic Obstructive Pulmonary Disease (COPD) ever undertaken. COPD is now the third leading cause of death in the U.S....

2014-07-23 16:27:13

Patients, caregivers and health care professionals share stories; offer awareness, hope and inspiration CHICAGO, July 23, 2014 /PRNewswire-USNewswire/ -- Twenty of the Pulmonary Fibrosis Foundation's advocates have come together to inaugurate PFF Ambassador program, a group of idiopathic pulmonary fibrosis (IPF) patients and caregivers who are committed to share personal stories of living with IPF as well as health care providers who deliver current disease education information to...

2014-07-21 20:22:22

Nintedanib and Pirfenidone Received Breakthrough Therapy Designation by the U.S. Food and Drug Administration (FDA) - PFF Disease Education Webinars scheduled CHICAGO, July 21, 2014 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) is pleased to announce two upcoming webinars, one of which is related to the U.S. Food and Drug Administration (FDA) granting breakthrough therapy designation for two new investigational treatments for idiopathic pulmonary fibrosis (IPF)....

2014-07-15 10:29:05

BMJ-British Medical Journal Inability to register surprise strongest indicator; can help prioritize care, say doctors Patients with serious heart and lung conditions don't have the normal range of facial expressions, particularly the ability to register surprise in response to emotional cues, finds preliminary research published online in Emergency Medicine Journal. This finding could be used to help busy emergency care doctors decide whom to prioritize for treatment, and gauge who...


Latest Pulmonology Reference Libraries

0_f9fe10c6664d20ba0d9091907b66a65f
2011-01-05 16:00:36

Human parainfluenza viruses, belonging to the paramyxovirus family, are a group of four distinct serotypes of enveloped single-stranded RNA viruses. They are the second most common cause of lower respiratory tract infection in younger children. Many times the host has repeat infections throughout life with symptoms that may include upper respiratory tract illness or more commonly, a cold and sore throat. It can also cause severe pneumonia in immunosuppressed people. There is currently no...

More Articles (1 articles) »
Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related